Myelofibrosis with myeloid metaplasia

被引：22
作者：
Barosi, G [1 ]
机构：
[1] Policlin San Matteo, IRCCS, Lab Med Informat, I-27100 Pavia, Italy
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 05期
关键词：
D O I：
10.1016/S0889-8588(03)00080-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Myelofibrosis with myeloid metaplasia is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and neoangiogenesis, constitutive release of a high number of CD34+ stem cells from the bone marrow, and extramedullary hematopoiesis. It presents with heterogeneous clinical features in which anemia and progression to symptomatic splenomegaly dominate. The pathogenesis is undefined. Allogeneic stem cell transplantation offers a chance of cure. Autologus stem cell transplantation and splenectomy are risky procedures that may be considered in advanced disease when conventional therapies for correcting anemia (danazol, recombinant human erythropoietin, cyclosporine) or chemotherapy for enlarging splenomegaly and myeloproliferation (hydroxy-urea or interferon alfa) have failed. Thalidomide has been tested in numerous series, and its capacity to improve anemia and thrombocytopenia while reducing splenomegaly has been documented.
引用
收藏
页码：1211 / +
页数：18
相关论文
共 80 条
[1]   Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis [J].
Anderson, JE ;
Tefferi, A ;
Craig, F ;
Holmberg, L ;
Chauncey, T ;
Appelbaum, FR ;
Guardiola, P ;
Callander, N ;
Freytes, C ;
Gazitt, Y ;
Razvillas, B ;
Deeg, HJ .
BLOOD, 2001, 98 (03) :586-593
[2]   Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines [J].
Barosi, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2954-2970
[3]   The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia [J].
Barosi, G ;
Ambrosetti, A ;
Finelli, C ;
Grossi, A ;
Leoni, P ;
Liberato, NL ;
Petti, MC ;
Pogliani, E ;
Ricetti, M ;
Rupoli, S ;
Visani, G ;
Tura, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) :730-737
[4]   A PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA [J].
BAROSI, G ;
BERZUINI, C ;
LIBERATO, LN ;
COSTA, A ;
POLINO, G ;
ASCARI, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (04) :397-401
[5]  
Barosi G, 1990, Haematologica, V75 Suppl 4, P48
[6]  
BAROSI G, 1981, BRIT J HAEMATOL, V48, P263
[7]   Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia [J].
Barosi, G ;
Viarengo, G ;
Pecci, A ;
Rosti, V ;
Piaggio, G ;
Marchetti, M ;
Frassoni, F .
BLOOD, 2001, 98 (12) :3249-3255
[8]  
BAROSI G, 1993, LEUKEMIA, V7, P200
[9]  
Barosi G, 1998, BLOOD, V91, P3630
[10]   EXTRAMEDULLARY HEMATOPOIESIS MANIFESTING AS A SYMPTOMATIC PLEURAL EFFUSION [J].
BARTLETT, RP ;
GREIPP, PR ;
TEFFERI, A ;
CUPPS, RE ;
MULLAN, BP ;
TRASTEK, VF .
MAYO CLINIC PROCEEDINGS, 1995, 70 (12) :1161-1164
12345678